Both semaglutide and tirzepatide are well-known for their effects on weight loss and blood sugar control, but our study suggests they may also offer substantial benefits to patients with obesity and type 2 diabetes by reducing adverse heart failure outcomes. Both drugs were also linked to acceptable safety profiles. Krger et al
Contact us today to schedule a consultation and take the first step towards a healthier, more radiant you
10.21926/obm.icm.2102015 27
Microdosing refers to lower-than-standard doses of semaglutide with slower increases
Patients often report looser clothing, reduced bloating, and visible changes in face and neck before overall scale weight drops significantly
Prekurzory glutathionu Nkter doplky obsahuj prekurzory glutathionu, jako je N-acetylcystein (NAC), alfa-lipoov kyselina nebo selen, kter pomhaj stimulovat pirozenou produkci glutathionu v tle